Emmaus Life Sciences Inc (EMMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 3,234 | 3,020 | 5,766 | 6,489 | 5,335 |
| Cost of Goods | 1,007 | 2,001 | 445 | 430 | 436 |
| Gross Profit | 2,227 | 1,019 | 5,321 | 6,059 | 4,899 |
| Operating Expenses | 5,302 | 5,985 | 5,797 | 6,006 | 6,950 |
| Operating Income | -3,068 | -4,965 | -31 | 483 | -1,615 |
| Interest Expense | 737 | 711 | 683 | 653 | 1,054 |
| Other Income | 2,160 | -1,219 | -2,205 | 2,467 | -5,735 |
| Pre-tax Income | -1,645 | -6,895 | -2,919 | 2,297 | -8,404 |
| Income Tax | -103 | -33 | 232 | -192 | 18 |
| Net Income Continuous | -1,542 | -6,862 | -3,151 | 2,489 | -8,422 |
| Net Income | $-1,542 | $-6,862 | $-3,151 | $2,489 | $-8,422 |
| EPS Basic Total Ops | -0.03 | -0.14 | -0.06 | 0.05 | -0.17 |
| EPS Basic Continuous Ops | -0.03 | -0.14 | -0.06 | 0.05 | -0.17 |
| EPS Diluted Total Ops | -0.03 | -0.14 | -0.06 | 0.05 | -0.17 |
| EPS Diluted Continuous Ops | -0.03 | -0.14 | -0.06 | 0.05 | -0.17 |
| EBITDA(a) | $-2,642 | $-4,550 | $365 | $857 | $-931 |